Calypso Medical
Develops tumor localization systems designed to accurately and objectively track the location of tumors in human bodies
About Calypso Medical
Calypso Medical is a pioneering company in the field of radiation oncology, specializing in advanced cancer treatment technologies. The company serves radiation oncologists, clinicians, and therapists by providing cutting-edge tools designed to enhance the precision and efficiency of cancer treatments. Operating in the healthcare technology market, Calypso Medical focuses on developing AI-powered systems like Ethos therapy, which personalizes cancer care and completes adaptive treatments within a typical 15-minute timeslot. Their Proton Therapy System offers next-generation proton therapy with ultra-high dose rates and exceptional precision, all within a compact design. The business model revolves around selling these high-tech medical devices and systems to healthcare providers, generating revenue through direct sales, service contracts, and after-sales support. Calypso Medical aims to instill confidence in both healthcare professionals and patients by integrating seamlessly with existing tools and providing comprehensive support resources.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Sep 2011 | $0 | — | Varian Medical Systems | — |
| DEBTDebt | Mar 2011 | $7.5M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Calypso Medical is 180 monthly website visits. Calypso Medical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Calypso Medical in the Seattle ecosystem
The Calypso Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later11 investors entered at this stage
Earlybird Venture Capital- BCBay City Capital
Versant Ventures
Frazier Healthcare Partners- IVIntegra Ventures
RiverVest Venture Partners- MBMerlin Biomed
Kaiser Permanente Ventures- ACApothecary Capital
Skyline Ventures
InterWest Partners
Other known investors1 additional known investor
Varian Medical Systems
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Calypso Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Calypso Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









